LSL Pharma Group Inc (LSL) Price & Analysis

2 Followers

LSL Stock Chart & Stats

C$0.34

C$0.01(2.82%)

At close: Jul 27 4:00 PM EDT

C$0.34

C$0.01(2.82%)

Day’s Range― - ―

52-Week RangeC$0.30 - C$0.56

Previous CloseN/A

Volume77.00K

Average Volume (3M)35.64K

Market Cap

C$41.19M

Enterprise ValueC$89.55

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.52

Next Earnings

Dec 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding126,729,820

10 Day Avg. Volume25,562

30 Day Avg. Volume35,636

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

LSL Pharma Group Inc News

LSL Pharma Delivers Record Q2 Revenue as Eye-Care and Private Label Drive Growth

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an announcement. LSL Pharma Group reported record second-quarter 2026...

1M ago

LSL Pharma to Highlight Growth Story at 2026 Bloom Burton Healthcare Investor Conference

LSL Pharma Group Inc ( ($TSE:LSL) ) has issued an announcement. LSL Pharma Group Inc., a Canadian integrated...

5M ago

LSL Pharma’s Juno OTC Expands Allergy Portfolio With New Loratadine RDT Deal

The latest announcement is out from LSL Pharma Group Inc ( ($TSE:LSL) ). LSL Pharma Group’s Juno OTC...

6M ago

LSL Pharma Grants 960,000 Stock Options to Directors, Executives and Staff

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group has granted a total...

8M ago

LSL Pharma Wins FDA Nod for Ophthalmic Ointment Manufacturing, Unlocking U.S. Market Access

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group has obtained U.S. FDA...

8M ago

LSL Pharma Closes Juno OTC Acquisition and Completes $12 Million Financing Package

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an announcement. LSL Pharma Group Inc. has completed the...

9M ago

LSL Pharma Raises $10 Million and Moves to Acquire Juno OTC

LSL Pharma Group Inc ( ($TSE:LSL) ) has provided an update. LSL Pharma Group has closed a $10...

9M ago

LSL Pharma Group Acquires Juno OTC Inc. and Secures $11M Fundraising

LSL Pharma Group Inc ( ($TSE:LSL) ) just unveiled an update. LSL Pharma Group Inc. has announced the...

9M ago

LSL Pharma Group Achieves Record Q3 Revenues and Expands Operations

LSL Pharma Group Inc ( ($TSE:LSL) ) has issued an announcement. LSL Pharma Group Inc. reported its fourth...

10M ago

LSL Pharma Group Expands Production Capacity with Du-Var Acquisition

LSL Pharma Group Inc ( ($TSE:LSL) ) has shared an update. LSL Pharma Group Inc. has completed the...

10M ago

LSL FAQ

What was LSL Pharma Group Inc’s price range in the past 12 months?

LSL Pharma Group Inc lowest stock price was C$0.30 and its highest was C$0.56 in the past 12 months.

What is LSL Pharma Group Inc’s market cap?

LSL Pharma Group Inc’s market cap is C$41.19M.

When is LSL Pharma Group Inc’s upcoming earnings report date?

LSL Pharma Group Inc’s upcoming earnings report date is Dec 01, 2026 which is in 66 days.

How were LSL Pharma Group Inc’s earnings last quarter?

LSL Pharma Group Inc released its earnings results on Aug 25, 2026. The company reported -C$0.018 earnings per share for the quarter.

Is LSL Pharma Group Inc overvalued?

According to Wall Street analysts LSL Pharma Group Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does LSL Pharma Group Inc pay dividends?

LSL Pharma Group Inc does not currently pay dividends.

What is LSL Pharma Group Inc’s EPS estimate?

LSL Pharma Group Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does LSL Pharma Group Inc have?

LSL Pharma Group Inc has 126,729,820 shares outstanding.

What happened to LSL Pharma Group Inc’s price movement after its last earnings report?

LSL Pharma Group Inc reported an EPS of -C$0.018 in its last earnings report. Following the earnings report the stock price went down -4.286%.

Which hedge fund is a major shareholder of LSL Pharma Group Inc?

Currently, no hedge funds are holding shares in TSE:LSL

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

LSL Pharma Group Inc

LSL Pharma Group, Inc. operates as a pharmaceutical company. It specializes in the development, manufacture and distribution of natural health products and dietary supplements in solid dosage forms as well as sterile ophthalmic pharmaceutical products. The company was founded on July 12, 2010 and is headquartered in Boucherville, Canada.